Instant Case Decision

See if you qualify for Power Morcellator Litigation and the right to potentially significant financial recovery.

The Power Morcellator Instant Case Evaluator provides lawsuit qualification information and details regarding your situation.

  1. Did you undergo a fibroid removal surgery?
  2. Were you diagnosed with uterine cancer?

View Your Report

Power Morcellator Linked to Uterine Cancer

Laparoscopic power morcellators are tools used in fibroid removal procedures that cut up uterine growth so that the growth can be more easily removed using noninvasive procedures. They could be used as part of either a myomectomy (removal of uterine fibroids) or hysterectomy (removal of uterus). The power morcellator essentially cuts uterine growth (fibroids) into very small pieces that can be removed by vacuum through a small incision.

Power Morcellator Lawsuits

Numerous women have filed morcellator lawsuits against Johnson & Johnson and other manufacturers of these morcellation devices, alleging they were not informed of the risks before undergoing their laparoscopic procedures.

In order to streamline early trial proceedings and make the process more convenient and efficient for all parties involved, federal court cases involving Ethicon power morcellators were coordinated into multidistrict litigation (MDL) in Kansas. The MDL is used to determine pretrial rulings in cases that involve many plaintiffs but a common question of fact. Cases currently pending in the MDL will be transferred back to their originating court for trial if settlement does not occur prior to trial.

Women who believe that their cancer diagnosis was made worse as a result of their choice to undergo a less invasive fibroid surgery or hysterectomy are currently filing lawsuits.

In April 2014, the U.S. Food and Drug Administration (FDA) issued a safety communication to warn physicians and patients that power morcellators could spread undetected cancer cells. Because there is no definitive way to know for sure if cancer cells are present prior to a procedure, the FDA recommended at the time that patients be counseled on the risks associated with power morcellators.

The agency also advised that morcellators should not be used in the majority of hysterectomies and myomectomies, since vaginal procedures are typically associated with better results and fewer complications.

Suffering From Uterine Cancer After Fibroid Removal Surgery?
Get Instant Online Analysis Now!

Johnson & Johnson Recalls Power Morcellators

As a result of a public outcry and the FDA warning, the largest manufacturer of the Power Morcellator tool, Johnson & Johnson, pulled the device off the market but there are still women today learning of the connection between a laparoscopic procedure and their uterine cancer diagnosis.

Power Morcellator Used in Large Numbers Prior to Recall

Many women choose to undergo laparoscopic hysterectomy or myomectomy because it is associated with benefits such as a shorter post-operative recovery time and reduced risk of infection compared to abdominal hysterectomy and myomectomy.

The minimally invasive nature of surgery involving a power morcellator made it an appealing choice for many women undergoing hysterectomies or myomectomies until Johnson & Johnson pulled the device from the market. According to investigations, Approximately 1 in 350 women undergoing these types of surgeries have an undetected form of uterine cancer. In these women, there is a risk that the morcellator will spread the cancerous tissue, decreasing the likelihood of long-term survival.

After public outcry and pressure from medical professionals, the FDA issued a strong warning regarding the use of power morcellators, in which it discouraged their use and directed surgeons to discuss the risks of using power morcellators with their patients.

Should you file a Power Morcellator Lawsuit to protect your legal rights?

Did you undergo one of these surgeries?

Fibroid Removal

Hysterectomy

Myomectomy

Were you diagnosed with one of the following?

Adenocarcinoma (or endometrial cancer)

Uterine Sarcoma

Carcinosarcoma

Endometrial stromal sarcoma

Leiomyosarcoma (LMS)

Myelosarcoma

If you answered yes to these two questions you should look into your legal rights. Fill out our Secure Power Morcellator Instant Case Evaluation if you believe you may need to protect your legal rights.

View Your Power Morcellator Case Analysis Now!

Instant, Secure, No cost/No obligation Analysis of Your Power Morcellator Lawsuit

Loading…
Background
Was a “Power Morcellator" used in your non-invasive surgery?
Which surgery did you have?
What state was the surgery performed in?
When did you have the surgery?
Health Effects
Please note which cancer you have been diagnosed with, if any:
When were you diagnosed?
Additional Information
Please add any additional information that will help us determine if you or your loved one qualifies for compensation.
View Report
Receive instant case analysis upon submission of this form.

Latest Power Morcellator News

October 17, 2016

Study Examines Cancer Risk Associated With Morcellation

Although the use of power morcellators during non-invasive gynecological procedures has declined significantly following FDA warnings issued in 2014 associating the device with the spread of uterine cancer, the cancer risk did not go down, according to a study published ...
May 17, 2016

JAMA: New Morcellation Device Does Not Eliminate Cancer Risk

The tissue containment system recently approved by the U.S. Food and Drug Administration for use with certain laparoscopic power morcellators does not eliminate the cancer risk associated with power morcellators, cautions a report published May 17 in the Journal of ...
May 8, 2016

FDA Approves New Power Morcellator Tissue Containment Device

The U.S. Food and Drug Administration (FDA) has announced the approval of a new containment device for use with certain power morcellators. The PneumoLiner system is designed to effectively isolate and contain uterine tissue not believed to be cancerous that ...